SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tokyo VD who wrote (5797)10/2/1998 6:26:00 PM
From: dino  Read Replies (1) of 7041
 
Tokyo, thanks for the response.......

Due to disclosure of details, I feel we will never be able to compare the two contracts. The amount of costs ICOS will incur to further develop, manufacture, and market the product is just one of the unknown areas.

I will say that the $75 million upfront payment before phase III completion seems very generous. Maybe there is a clause of partial return if the results are not significant.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News